David Rooklin Email

Cofounder, CEO . Redesign

Current Roles

Employees:
32
Revenue:
$5M
About
Redesign Science develops and applies a molecular dynamics-driven platform for in silico drug discovery against emerging drug target classes. We work in partnership with Biotech and Pharma to co-develop novel small molecule therapeutics.
Redesign Address
180 Varick St
New York, NY
United States
Redesign Email

Past Companies

Redesign ScienceCofounder, CEO
New York UniversityResearch Associate
New York UniversityPostdoctoral Research Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.